The assay results revealed that the introduction of the PI3K/AKT inhibitor reversed the enhanced invasiveness of these osteosarcoma cells (Figure 6 a and b) and that these effects were concentration dependent (Figure 6c), confirming the direct relationship between STEAP2 and the PI3K/AKT pathway. The gene discussed is STEAP2; the disease is osteosarcoma.